Beckman Coulter Division President Albert Ziegler Announces Retirement.Business Editors & Health/Medical Writers FULLERTON, Calif.--(BUSINESS WIRE)--March 18, 2002 Albert Ziegler, 63, president of the Clinical Diagnostics Division at Beckman Coulter This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. , Inc. (NYSE NYSE See: New York Stock Exchange :BEC), today announced plans to retire, effective April 15, 2002, bringing to a close more than 15 years with the company. Ziegler will continue with Beckman Coulter in a consulting capacity through the end of the year in order to ensure a seamless transition for his successor, who will be named in the near future. "Albert has been instrumental in building the Clinical Diagnostics Division into a $1.5 billion organization that is poised to realize even greater market success," said Beckman Coulter's Chairman, President and Chief Executive Officer John P. Wareham. "As the senior division executive, he was the driving force behind the emphasis on developing instrument systems and supplies that help clinical diagnostics laboratories realize greater efficiencies through workstation consolidation and process automation." Ziegler joined the company as vice president, North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. operations for the diagnostics systems group in 1986 and moved into positions of increasing responsibility over the years, including vice president, diagnostics development centers and vice president, clinical chemistry division. Earlier in his career, he had held leadership positions at Branson Ultrasonics ultrasonics, study and application of the energy of sound waves vibrating at frequencies greater than 20,000 cycles per second, i.e., beyond the range of human hearing. Corporation and Emerson Electric. Beckman Coulter, Inc. is a global biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. company, headquartered in Fullerton, California Fullerton is a city located in northern Orange County, California, United States. As of the 2000 census, the city had a total population of 126,003. It was founded in 1887 by George and Edward Amerige and named for George H. . The company develops and markets instruments, chemistries, software and supplies that simplify and automate laboratory processes throughout the biomedical testing biomedical test A test intended to evaluate qualitative or quantitative derangements in physiology and predict impaired health due to exposure to hazardous materials continuum. Through pioneering medical research and drug discovery, specialty testing, and patient care diagnostics, Beckman Coulter supports all phases of the battle against disease. Annual sales for the company totaled $2 billion in 2001, with 62% of this amount generated by recurring revenue from supplies, chemistry kits and services. For more information about the company, visit www.beckmancoulter.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion